News

Sunshine Biopharma announces results from studies on K1.1-mRNA-LNP product
Sunshine Biopharma (SBFM) has completed additional studies on orthotopic human tumor models in mice confirming its K1.1 mRNA Lipid ...
Sunshine Biopharma Stock Shoots Higher On Encouraging Data From mRNA-Based Liver Cancer Drug
Sunshine Biopharma's K1.1 mRNA-LNP shows promise for HCC treatment in mice, while its 2024 revenue surged 45% to $34.9 ...
Sunshine Biopharma Announces Positive Results of mRNA Therapy for Cancer
FORT LAUDERDALE, FL / ACCESS Newswire / April 2, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) ("We", "Our", the "Company"), a ...
News-Medical.Net on MSN10d
Triple therapy reduces tumor burden and improves survival in glioblastoma models
A new research paper was published in Oncotarget, Volume 16, on March 27, 2025, titled "Imipridones ONC201/ONC206 + RT/TMZ ...
Physician's Weekly13d
Impact of Urinary Diversion Choices on Quality of Life After Cystectomy
The following is a summary of “Health-related quality of life after radical cystectomy for bladder cancer in elderly patients ...
Sunshine Biopharma Inc.: Sunshine Biopharma Announces Positive Results of mRNA Therapy for Cancer
FORT LAUDERDALE, FL / ACCESS Newswire / April 2, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) ("We", "Our", the "Company"), a pharmaceutical company offering and researching life-saving medicines in a ...